Quantitative real-time reverse Transcription-PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non-small cell lung cancer

被引:29
|
作者
Zygalaki, Eleni
Tsaroucha, Emily G.
Kaklamanis, Loukas
Lianidou, Evi S. [1 ]
机构
[1] Univ Athens, Dept Chem, Analyt Chem Lab, GR-15771 Athens, Greece
[2] Sotiria Gen Hosp, Athens 11526, Greece
[3] Onassis Cardiac Surg Ctr, Dept Pathol, Athens 17674, Greece
关键词
D O I
10.1373/clinchem.2007.086819
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis and its expression is increased in non-small cell lung cancer (NSCLC). We aimed to determine the expression pattern of VEGF splice variants in NSCLC and its correlation with the clinicopathological characteristics of tumors. Methods: We used real-time reverse transcription PCR to quantify the mRNA expression of total VEGF, 4 VEGF splice variants (VEGF(121), VEGF(165), VEGF(183), and VEGF(189),), and 2 VEGF receptors (VEGFR-1 and VEGFR-2) in 27 pairs of cancerous and adjacent noncancerous tissues originating from patients with NSCLC. Results: Total VEGF, VEGF(121), and VEGF(165), were expressed in all specimens, whereas VEGF(183), and VEGF(189). were present in small amounts in certain samples. Total VEGF, VEGF(121), and VEGF(165) mRNA was upregulated in cancerous compared with healthy tissues, whereas VEGF(183) and VEGF(189) expression tended to be higher in healthy tissues. The expression of VEGFRs was similar between matched specimens. No correlation was found between the expression of total VEGF or VEGF splice variants and the clinicopathological characteristics of tumors. The expression patterns of VEGF splice variants differed between tissue pairs. VEGF(121) was the major variant expressed in all samples; however, its relative expression was higher in cancerous tissues. The relative expression of VEGF(183) and VEGF(189) was upregulated in healthy lung tissues, whereas the ratio of VEGF(165) to total VEGF was similar between matched specimens. Conclusions: The expression pattern of certain VEGF splice variants is altered during tumorigenesis. Our data support the hypothesis that during malignant progression an angiogenic switch favoring the shorter diffusible isoforms occurs. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:1433 / 1439
页数:7
相关论文
共 50 条
  • [1] Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR
    Yuan, A
    Yu, CJ
    Luh, KT
    Chen, WJ
    Lin, FY
    Kuo, SH
    Yang, PC
    [J]. LABORATORY INVESTIGATION, 2000, 80 (11) : 1671 - 1680
  • [2] Basal and squamous cell carcinomas: Differences in the vasculature, vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1) and VEGF receptor-2 (VEGFR-2) expression
    Tsiatoura, Amalia
    Batistatou, Anna
    Zioga, Aikaterini
    Agnantis, Niki J.
    Stefanou, Dimitrios
    [J]. VIRCHOWS ARCHIV, 2007, 451 (02) : 536 - 537
  • [3] Real-time reverse transcription-PCR quantification of vascular endothelial growth factor splice variants
    Zygalaki, E
    Stathopoulou, A
    Kroupis, C
    Kaklamanis, L
    Kyriakides, Z
    Kremastinos, D
    Lianidou, ES
    [J]. CLINICAL CHEMISTRY, 2005, 51 (08) : 1518 - 1520
  • [4] Expression of vascular endothelial growth factor a (VEGF-A), VEGF receptor 1 (VEGFR-1) and VEGFR-2 in clear cell and papillary renal cell carcinoma (RCC): Implications for therapy
    Leppert, JT
    Lam, JS
    Yu, H
    Seligson, DB
    Dong, J
    Horvath, S
    Pantuck, AJ
    Figlin, RA
    Belldegrun, AS
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 362 - 362
  • [5] Expression of Vascular Endothelial Growth Factor Receptor 1(VEGFR-1), but not VEGFR-2 in Activated T Lymphocytes and Its Function in Response to VEGF
    Shin, Jin Young
    Kim, Jung Sik
    Kim, Bongi
    Yun, Il Hee
    Park, Chung Gyo
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178
  • [6] Localization of vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in bovine placentomes from implantation until term
    Pfarrer, C. D.
    Ruziwa, S. D.
    Winther, H.
    Callesen, H.
    Leiser, R.
    Schams, D.
    Dantzer, V.
    [J]. PLACENTA, 2006, 27 (08) : 889 - 898
  • [7] Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology
    Wellmann, S
    Taube, T
    Paal, K
    von Einsiedel, MG
    Geilen, W
    Seifert, G
    Eckert, C
    Henze, G
    Seeger, K
    [J]. CLINICAL CHEMISTRY, 2001, 47 (04) : 654 - 660
  • [8] Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
    Capp, Clarissa
    Wajner, Simone Magagnin
    Siqueira, Debora Rodrigues
    Brasil, Beatriz Assis
    Meurer, Luise
    Maia, Ana Luiza
    [J]. THYROID, 2010, 20 (08) : 863 - 871
  • [9] Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients
    Zeki Ustuner
    Pinar Saip
    Vildan Yasasever
    Burcak Vural
    Aziz Yazar
    Cengiz Bal
    Betul Ozturk
    Ugur Ozbek
    Erkan Topuz
    [J]. Medical Oncology, 2008, 25 : 394 - 399
  • [10] Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients
    Ustuner, Zeki
    Saip, Pinar
    Yasasever, Vildan
    Vural, Burcak
    Yazar, Aziz
    Bal, Cengiz
    Ozturk, Betul
    Ozbek, Ugur
    Topuz, Erkan
    [J]. MEDICAL ONCOLOGY, 2008, 25 (04) : 394 - 399